StevenWilliamCorsoMD

Oncology • Spartanburg, SC

Physician

Join to view full profile

Dr. Corso is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Corso's full profile

Already have an account?

Office
101 E Wood St
Spartanburg, SC 29303
Phone+1 864-560-7050

Fax+1 864-560-0800

Education & Training

San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1991 - 1994
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1988 - 1991
University of South Carolina School of MedicineClass of 1988

Certifications & Licensure

SC State Medical License 1997 - 2025
NC State Medical License 1995 - 1998
TN State Medical License 1996 - 1998
PA State Medical License 1990 - 1996
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome Start of enrollment: 2015 Dec 23
Completed
Not Applicable
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

335 citations
Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma
John D. Hainsworth, Sharlene Litchy, Howard A. Burris, Daniel C. Scullin, Steven W. Corso
Journal of Clinical Oncology. 2002-10-15
40 citations
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
Daniel L. Hertz, Anna C. Snavely, Howard L. McLeod, Christine M. Walko, Joseph G. Ibrahim
British Journal of Clinical Pharmacology. 2015-11-01
66 citations
Phase III Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressa...
Charles L. Loprinzi, John W. Kugler, Debra L. Barton, Amylou C. Dueck, Loren K. Tschetter
Journal of Clinical Oncology. 2007-01-20

Professional Memberships

American College of Physicians - ACP
Member
American Society of Clinical Oncology - ASCO
Member